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Abstract
Objective To determine the effectiveness of helmet therapy for positional
skull deformation compared with the natural course of the condition in
infants aged 5-6 months.
Design Pragmatic, single blinded, randomised controlled trial (HEADS,
HElmet therapy Assessment in Deformed Skulls) nested in a prospective
cohort study.
Setting 29 paediatric physiotherapy practices; helmet therapy was
administered at four specialised centres.
Participants 84 infants aged 5 to 6 months with moderate to severe
skull deformation, who were born after 36 weeks of gestation and had
no muscular torticollis, craniosynostosis, or dysmorphic features.
Participants were randomly assigned to helmet therapy (n=42) or to
natural course of the condition (n=42) according to a randomisation plan
with blocks of eight.
Interventions Six months of helmet therapy compared with the natural
course of skull deformation. In both trial arms parents were asked to
avoid any (additional) treatment for the skull deformation.
Main outcome measures The primary outcome was change in skull
shape from baseline to 24 months of age assessed using
plagiocephalometry (anthropometric measurement instrument). Change
scores for plagiocephaly (oblique diameter difference index) and
brachycephaly (cranioproportional index) were each included in an
analysis of covariance, using baseline values as the covariate. Secondary
outcomes were ear deviation, facial asymmetry, occipital lift, and motor
development in the infant, quality of life (infant and parent measures),
and parental satisfaction and anxiety. Baseline measurements were
performed in infants aged between 5 and 6 months, with follow-up
measurements at 8, 12, and 24 months. Primary outcome assessment
at 24 months was blinded.
Results The change score for both plagiocephaly and brachycephaly
was equal between the helmet therapy and natural course groups, with
a mean difference of −0.2 (95% confidence interval −1.6 to 1.2, P=0.80)
and 0.2 (−1.7 to 2.2, P=0.81), respectively. Full recovery was achieved
in 10 of 39 (26%) participants in the helmet therapy group and 9 of 40
(23%) participants in the natural course group (odds ratio 1.2, 95%
confidence interval 0.4 to 3.3, P=0.74). All parents reported one or more
side effects.
Conclusions Based on the equal effectiveness of helmet therapy and
skull deformation following its natural course, high prevalence of side
effects, and high costs associated with helmet therapy, we discourage
the use of a helmet as a standard treatment for healthy infants with
moderate to severe skull deformation.
Trial registration Current Controlled Trials ISRCTN18473161.
Introduction
Positional skull deformation is a condition in which the shape
of an infant’s skull deforms as a result of prolonged external
forces. The infant’s head is malleable and growing rapidly,
hence it is susceptible to deformation, especially when infants
develop a positional preference of the head when lying in the
supine position.1 Two typical components of skull deformation
are unilateral occipital flattening of the skull (plagiocephaly)
and symmetrical occipital flattening (brachycephaly).2A strong
plagiocephalic flattening is often presented with ipsilateral
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frontal bossing of the forehead and anterior shift of the ipsilateral
ear (ear deviation) and cheek (see web extra fig 1A).3-5
Brachycephaly can be accompanied by temporal bossing or an
occipital lift (see web extra fig 1B).3
Skull deformation is generally considered a cosmetic condition.
Developmental delays are regularly associated with skull
deformation,6-9 but the deformation is increasingly seen as a
marker for delays, instead of causing the delays.6-8 Parents fear
the negative physical and psychosocial effects of skull
deformation on their child.10 11
The prevalence of skull deformation increased substantially
after it was recommended that infants should be placed in a
supine sleep position to prevent sudden infant death
syndrome.12-18Nowadays skull deformation seemsmost prevalent
between two (16-22%) and four months (20%) after birth.19 20
The prevalence drops when infants become older.1 19-21
The preferred treatment is usually conservative. In a recently
published guideline (2012), the Netherlands Centre of Preventive
Child Health Care advised to start counselling parents during
well baby visits on the handling and repositioning infants with
an observed positional preference or skull deformation. When
no improvement is seen at follow-up visits, infants are referred
for paediatric physiotherapy.22 23 Infants younger than 4 months
may benefit from active repositioning, yet not all show
improvement.22 24 25 As most infants show symmetry in posture
at 5 or 6 months of age,1 22 no effects of continued paediatric
physiotherapy can be expected. In infants with persistent skull
deformation at 6 months of age, orthotic helmets or headbands
are often prescribed.26-28 A helmet is a cranial orthosis made up
of a rigid plastic shell with a foam lining. The helmet is expected
to redirect skull growth by fitting closely to the infant’s head
but leaving room for the skull to grow at the flattened area. The
helmet is recommended to be worn for 23 hours a day from 6
to 12 months of age. In the Netherlands 1-2% of infants (176
000 newborns in 201229) received helmet therapy for skull
deformation.
Since conclusive evidence from randomised trials is lacking,
the clinical benefit of helmet therapy compared with the natural
course of skull deformation remains unknown. The few
prospective comparative studies to date tend to show positive
results in favour of helmet therapy but have several
limitations.5 30-33 Long term outcomes and assessment of side
effects are missing in most studies and the clinical relevance of
the reported effects is questionable.26 28 34 35
TheHElmet therapyAssessment in Deformed Skulls (HEADS)
study is a randomised controlled trial designed to compare
helmet therapy for six months with the natural course of
positional skull deformation in infants aged 6 months. Although
helmet therapy is expected to give slightly better results in the
short term, we hypothesised that the natural course of skull
deformation would catch up with the effects of helmet therapy
over time and that no clinically meaningful differences would
be present between the two groups at 2 years of age.
Methods
Study design
The HEADS study is a two armed pragmatic randomised
controlled trial nested in a prospective cohort study (fig 1⇓).
The follow-up study was designed to catch all infants eligible
for helmet therapy after a period of paediatric physiotherapy or
a single consultation. We invited the parents of eligible infants
with moderate to severe skull deformation to include their child
in the study at 5 months of age. Participants were randomised
1:1 to either the helmet therapy arm or the natural course arm.
Follow-up assessments were performed at 8, 12, and 24 months
of age (fig 1). The primary outcome was anthropometric
measurement of the skull. A more detailed description of the
HEADS study is published elsewhere.36
Setting and participants
Recruitment for the randomised controlled trial was conducted
in 29 paediatric physiotherapy practices in the east of the
Netherlands between July 2009 and July 2011 by 29 specially
trained paediatric physiotherapists.We considered infants to be
eligible for the study if they had moderate to severe skull
deformation, were aged 5 to 6 months, were born after 36 weeks
of gestation, and had no muscular torticollis, craniosynostosis,
or dysmorphic features. The course for participating paediatric
physiotherapists included detailed information on differentiating
between synostotic and non-synostotic skull deformation and
between positional and congenital muscular torticollis.
We determined the severity of skull deformation in the
transversal plane using the oblique diameter difference index
and the cranioproportional index of plagiocephalometry (fig
2⇓).37 38 The oblique diameter difference index provides the
degree of the plagiocephalic component of skull deformation
and is the ratio between the longest cranial diagonal and the
shortest cranial diagonal (fig 2) multiplied by 100%, with both
located at 40° from the anterior-posterior line. In addition, we
determined the brachycephalic component using the
cranioproportional index, which is the ratio between the width
and the length of the skull (fig 2).
We included infants in the study if the oblique diameter
difference index was 108% or more or if the cranioproportional
index was 95% or more, or in the case of a mixed form if the
oblique diameter difference index was 106% or more and the
cranioproportional index was 92% or more. Infants with very
severe skull deformation were excluded (oblique diameter
difference index >113% or cranioproportional index >104%).
A value of 100% on the oblique diameter difference index
represents a symmetrical head shape. A value of more than
100% represents asymmetrical skull deformation; the higher
the score, the more severe the deformation. A score of 80% on
the cranioproportional index represents an average head shape
in Western countries. A higher value represents a larger head
width compared with length.
Randomisation and blinding
At age 5 months, the paediatric physiotherapists selected infants
meeting the inclusion criteria for the trial and requested informed
consent from the parents. The parents could consult an
independent doctor for questions related to trial participation.
After inclusion, infants were allocated to their trial arm by
computer generated randomisation in blocks of eight. An
independent researcher managed the randomisation plan. The
research team and parents were blinded for group allocation
until the parents had signed the informed consent form and
confirmed participation. A researcher (RMW) called the parents
and informed them about the randomisation allocation. It was
not possible to blind parents during the treatment period. The
infant’s paediatric physiotherapist, general practitioner, and
youth healthcare professional were informed about group
allocation after randomisation. Blinded outcome assessments
were, however, performed at the 24 month follow-up.
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Intervention and control group
Parents of infants allocated to the helmet therapy group were
asked to make an appointment at one of the four collaborating
institutes to obtain a custom-made helmet. Between the institutes
two brands of helmets were provided; both helmets used the
same mechanism to redirect skull growth. The aim was to start
helmet therapy in the infants no later than 6.5 months of age.
Parents were instructed to ensure that the helmet was worn for
23 hours a day until their infant was 12 months of age or until
satisfactory outcomes were obtained according to both parents
and professionals. Parents received additional information on
starting the helmet therapy, how the helmet should be worn,
cleaning the helmet, and general care. An orthotist regularly
monitored the infants for signs of pressure spots, and the helmet
was modified or replaced to accommodate skull growth as
necessary. The treatment was always supervised by a (paediatric)
doctor. During the intervention period, Dutch health insurance
companies reimbursed the costs of helmet therapy.
The control group did not receive helmet therapy and natural
skull growth was monitored.
Outcome measures
The paediatric physiotherapists performed measurements at
baseline and at age 5, 8, and 12 months. Six of the paediatric
physiotherapists who were involved in the study were selected
to perform the blinded assessments at 24 months in all infants.
Thesemeasurements were carried out from February 2011 until
March 2013. Every assessment included anthropometric
measurement of the skull’s shape, a clinical assessment of skull
deformation, a motor assessment, and a parental questionnaire.
The questionnaire was used to gather information on background
characteristics (sex, age, birth rank, health problems, ethnicity,
and educational level of the parents) at baseline and parent
reported outcomes during all assessments.
Therapy compliance
The questionnaire administered at 12 months was used to
determine whether parents were compliant with the regimen to
which their infant was assigned. The questionnaire assessed the
age of infants when treatment was discontinued and the reasons
for discontinuation. Parents were also asked whether they used
additional therapies. Furthermore, the questionnaires at 8 and
12 months also included questions about the fit of the helmet.
Originally the protocol specified that compliance would be
determined using data from an electronic device built into the
helmet to measure compliance with wear. Despite a pilot study,
data from the measuring devices proved to be unreliable and
we therefore omitted them from further analysis.
Primary outcome
Skull shape
The primary outcome was the anthropometric measurement of
the skull’s shape at 24 months using the oblique diameter
difference index and cranioproportional index.37 38 We
considered a difference in change score from age 5 to 24months
of 4 oblique diameter difference index points or 5
cranioproportional index points to be relevant between the
groups, consistent with one level of severity in skull deformation
according to plagiocephalometry criteria (fig 2). Additionally,
we report the number of infants who fully recovered, with full
recovery defined as an oblique diameter difference index of less
than 104% and a cranioproportional index of less than 90% (fig
2).
Secondary outcomes
Ear deviation
Severity of ear deviation was expressed by the ear deviation
index using plagiocephalometry. The ear deviation index is the
ratio between the ear deviation and the length of the skull (fig
2).
Facial asymmetry and occipital lift
During the clinical assessment the paediatric physiotherapists
reported the presence of any facial asymmetry and occipital lift.
Parental satisfaction
Parental satisfaction with their infant’s head shape was assessed
in the parental questionnaire using a five point Likert scale,
ranging from 1 (not satisfied at all) to 5 (very satisfied).
Motor development
At baseline, a paediatric physiotherapist assessed the repertoire
of gross motor movement using the Alberta infant motor scale,
a valid, norm-referencedmeasurement.We converted raw scores
on the scale into standardised Z scores, using the formula:
(individual score−average score)/standard deviation.39
To assess motor development at 24 months we used the Bayley
scales of infant and toddler development, third edition.40
Specially trained physiotherapists administered the test. We
converted raw scores to standardised motor composite scores
(mean 100 (SD 15)) and scaled scores for fine and gross motor
development separately (mean 10 (SD=3)).
Parental anxiety
We measured the level of parental state anxiety using the
Spielberger state trait anxiety inventory, Dutch version.41 The
state anxiety scale (20 items) concerns the state of anxiety of
parents at a specific moment, and scores range from 20 to 80;
a higher score represents a higher state of anxiety.
Quality of life
The infant toddler quality of life questionnaire—short form 47
is a parent reported measure that provides information about
the health status and health related quality of life in children
aged between 2 months and 5 years.42 Since the questionnaire
is a “proxy” measure and parental concern might influence
outcomes, parent specific scales are included. The questionnaire
consists of eight multi-item scales and two single items: the
child scales include physical abilities (six items), growth and
development (five), bodily pain (two), temperament andmoods
(six), behaviour (12), general health (six), and change in health
(one); the parent scales include parental-impact emotional (four
items), parental-impact time (four), and family cohesion (one).
Scores for all scales range from 0 to 100, with a higher score
indicating better health.
Side effects
The questionnaires at 8 and 12 months contained questions
about side effects associated with helmet therapy. In consultation
with health professionals we defined side effects as skin
irritation, pain, sweating, odour of the helmet, problems with
accepting the helmet, and feeling hindered in cuddling because
of the helmet. Furthermore, in both groups at 8 months parents
were asked about the number of hours their baby cried a day
and whether their baby had sleep problems. Criteria to define
sleep problems in infants are not used consistently in the
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literature43; in this study we defined sleep problems as taking
more than 20 minutes to fall asleep (daily), or waking more than
once every night.
Statistical analyses
The sample size of the randomised controlled trial of the
HEADS study was calculated at 72 (36 in each arm), based on
a significance level of 5%, a power of 90%, and a difference in
mean improvement of at least 4 (SD 6) oblique diameter
difference index points.
We described background and baseline clinical characteristics
of the sample for the total group as well as for the intervention
and control groups separately; continuous variables with means
and standard deviation, and discrete variables with counts and
percentages. In a subsequent analysis, we compared the baseline
characteristics of the intervention and control groups by means
of the independent t test or χ2 test. We determined the
representativeness of the randomised controlled trial population
by comparing background characteristics and baseline clinical
characteristics of the population with eligible non-participants
at age 5 months using the independent t test or χ2 test.
For analysis we used two continuous outcome variables
(plagiocephaly change score: oblique diameter difference index
at age 5 months minus 24 months; and brachycephaly change
score: cranioproportional index at age 5 months minus 24
months) and the dichotomous outcome variable (full recovery).
Treatment effect was presented as change score in the helmet
therapy group minus change score in the natural course group.
To test differences in the change scores between the groups, we
used analysis of covariance with baseline value (age 5 months)
as covariate. Thereafter we carried out multiple regression
analyses with baseline values (age 5 months), sex, and parental
level of education as covariates. We compared secondary
outcomes between groups by means of the independent t test
or χ2 test. To analyse the 10 subscales of the infant toddler
quality of life questionnaire we performed amultivariate analysis
of variance.
We compared the groups on an intention to treat basis.
Additionally, we carried out a per protocol analysis. Data
analysis was performed using SPSS (version 21.0), and we set
the level of significance at 0.05.
Results
Study population
At the start of this study, the paediatric physiotherapists
identified 403 eligible infants (47% of 866 assessed infants, fig
1). The parents of 84 infants (21%) agreed to participate in the
trial and those infants were assigned to two groups (42 infants
in each group). The main baseline personal and clinical
characteristics (sex, age, birth rank, health problems, ethnicity,
severity of skull deformation, motor development, and parental
satisfaction) did not differ significantly between those who
agreed to participate and the infants who were not enrolled,
except for the educational level of the parents, which was lower
among the participants (see web extra table). The background
characteristics of the two trial arms were comparable (table 1⇓).
A total of 79 infants (94%) were followed up at the final
assessment at 24 months (fig 2). The parents of two infants did
not show up for final assessments despite repeated attempts to
contact them, two families moved out of the study area, and the
parents of one infant could not be contacted.
All infants met the inclusion criteria for either the plagiocephalic
component of skull deformation (oblique diameter difference
index ≥108%) or the brachycephalic component
(cranioproportional index ≥95%), or both. The baseline
assessments showed statistically significant differences in the
shape of the infants’ skulls between the two groups (table 2⇓).
Infants in the natural course group presented with more severe
plagiocephaly and more often presented with facial asymmetry,
whereas infants in the helmet therapy group showed higher
brachycephaly scores andmore often showed the accompanying
occipital lift (table 2).
Therapy allocation and compliance
After randomisation, seven infants did not start the assigned
treatment. Six infants who were allocated to helmet therapy did
not start this treatment: in three cases the parents preferred to
allow the skull deformity to follow its natural course; in three
other cases the doctor advised against helmet therapy.
Additionally, parents of one infant allocated to the natural course
arm preferred helmet therapy.
In infants who started in the helmet therapy group, helmet
therapy was discontinued at a mean age of 10.0 months (SD 2.0
months, n=30). Ten of 30 infants received helmet therapy until
12 months of age. The main reasons for parents discontinuing
the helmet therapy before 12 months (n=20) was satisfaction
with results (n=8), side effects (n=10), dissatisfaction with the
results (n=1), and “other” (n=1). Problemswith fitting the helmet
were reported for 22 of 30 infants (73%); the helmet rotated or
shifted a few times a week to several times a day. Parents of
one infant reported that the helmet came off spontaneously.
Two infants in the natural course group received helmet therapy
after the 8 month assessment; the parents were not satisfied with
the skull shape.
Three infants in the helmet therapy group and two in the natural
course group received additional therapy during the intervention
period: manual therapy, osteopathy, or chiropractic.
Primary outcome
The plagiocephaly change score from age 5months to 24months
was almost equal for both groups (table 3⇓): the difference in
oblique diameter difference index, calculated as change score
in the helmet therapy group minus change score in the natural
course group, was −0.2 (95% confidence interval −1.6 to 1.2,
P=0.80). The brachycephaly change score from age 5 months
to 24 months was also almost equal for both groups, with a
difference in cranioproportional index of 0.2 (−1.7 to 2.2,
P=0.81). Additionally, the numbers of infants showing full
recovery were comparable in both groups (odds ratio 1.2, 95%
confidence interval 0.4 to 3.3).
When adjusting for baseline values, change scores between
groups did not differ significantly (adjusted difference in mean
plagiocephaly change score 0.9, 95% confidence interval −0.3
to 2.0 and in mean brachycephaly change score −1.0, −2.5 to
0.5). Adjusting for sex and parental level of education did not
alter the treatment effect (plagiocephaly change score: β=1.0
(−0.3 to 2.3), P=0.12; brachycephaly change score: β=−1.1
(−2.8 to 0.5), P=0.17).
A per protocol analysis of covariance (helmet therapy n=34,
natural course n=45) provided outcomes comparable to the
intention to treat analysis (plagiocephaly change score −0.4,
−1.8 to 1.1, P=0.31; brachycephaly change score 0.5, −1.5 to
2.4, P=0.11).
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Secondary outcomes
No significant differences were found for the additional clinical
outcomes, parent reported outcomes, and motor development.
Parents in both arms showed high scores for satisfaction with
their infants’ skull shape at 24 months (table 4⇓).
Finally, a multivariate analysis of variance revealed no
significant differences between groups for subscales on the
infant toddler quality of life questionnaire: Wilks’ λ=.826,
F10,63=1.3, P=0.24.
Side effects
The helmet therapy group had fewer sleep problems (helmet
therapy 5/35, 14%; natural course 10/41, 24%) and spent fewer
hours crying than the natural course group (helmet therapymean
1.4 (SD 1.2); natural course mean 1.2 (SD 0.9)), although these
differences were not significant. In the intervention group all
parents (35/35) reported one or more side effects related to
helmet therapy: problems with acceptance of the helmet (8/33,
24%), skin irritation (32/34, 96%), augmented sweating (24/34,
71%), unpleasant odour of the helmet (25/33, 76%), pain
associated with the helmet (9/27, 33%), and feeling hindered
from cuddling their child (24/31, 77%).
Discussion
This pragmatic randomised controlled trial found no evidence
of a significant or clinically meaningful difference in
improvement of skull shape at 2 years of age between infants
who were treated with helmet therapy and those in whom the
natural course of skull deformation was awaited. Despite
improvement in skull shape in both groups, only a quarter of
the participants showed full recovery. Overall, parents were
satisfied to very satisfied with the recovery of their infants’ skull
deformation at 2 years old. However, the parents of infants who
were treated with a helmet showed slightly higher satisfaction
scores and a slightly lower state of anxiety when their infants
were 2 years of age.
Helmet therapy did not influence the infants’ motor
development, quality of life, sleeping, or crying. Side effects
of helmet therapy were reported by all parents.
Strengths and limitations of this study
Strengths of this study include the randomised allocation of
treatment, nested design, high follow-up rates, use of various
long term outcomes measures, and both plagiocephaly and
brachycephaly being studied.
The HEADS trial is the first study to provide evidence from a
randomised controlled trial on the long term effectiveness of
helmet therapy for skull deformation. The nested design enables
us to determine the generalizability of study outcomes. As well
as having anthropometric outcome measures, this study
presented parent reported outcomes (for example, subjective
assessments and quality of life assessment) and side effects. A
high follow-up rate of 94% ensures the power of the study and
indicates that the follow-up was not selective.
The use of two outcome measures (oblique diameter difference
index and analysis of covariance) could be disputed. However,
positional skull deformation usually presents with components
of both brachycephaly and plagiocephaly and not just as one
type or the other.2 Moreover, helmets are prescribed for all
variations of moderate to severe positional skull deformation,
so we therefore included both components of skull deformation.
Limitations of this study include the difference of severity of
skull deformation at baseline between both arms of the trial, a
low participation rate, limited generalisability of study results
to specific subgroups of infants, and no assessment of daily
wearing time of the helmet.
Despite between group differences in the baseline clinical
characteristics at randomization, this was tackled using the
planned analysis of covariance for the comparison of mean
differences. The improvement assessed by anthropometric
measurements showed no differences at 24 months, yet the
parents of infants in the helmet therapy group showed slightly
higher satisfaction scores and lower anxiety levels. This might
be explained by the fact that simply offering treatment may
reassure parents.
The parents of 21% of eligible infants agreed to participate in
the trial. Participating parents had a lower level of education
than non-participating parents. It has been described before that
parents with a higher level of education might have stronger
preferences for treatment and are thereby less likely to agree
with randomisation.44 45
Another limitation of the study is that the results concern infants
with moderate to severe skull deformation and therefore are not
generalisable to cases of very severe skull deformation. We
decided to exclude very severe cases, since we expected
selection bias on the basis of severity of the deformation and
selective loss to follow-up in infants with very severe skull
deformation who would have been allocated to the natural
course. Eventually, only 29/432 (7%) of infants who were
eligible for helmet therapy at age 5 months were excluded on
the basis the severity of skull deformation. Results are also not
generalisable to infants with an underlying congenital condition
or muscular torticolllis, or infants who were born preterm.
Inclusion of infants born preterm would have complicated the
treatment protocol and the interpretation of outcomes. The
prevalence of positional skull deformation in infants born
preterm is high, but the natural course seems favourable.46
Additionally, in infants born preterm the corrected age has to
be used for the start of treatment and outcome measurements,
which would have complicated interpretation and the
generalisability of study outcomes.
A final limitation is that we were not able to study the exact
wear time of the helmet. However, in this pragmatic study we
wanted to study the effect of helmet therapy in routine everyday
practice, including parent instructions and regular check-ups to
monitor treatment and assess improvements in skull shape.
Strengths andweaknesses in relation to other
studies
The various literature reviews suggest that helmet therapy may
bemore effective in correcting skull deformation in infants aged
6 months than other conservative treatments, but urge the need
for evidence from randomised controlled trials.26 28 34 35 47
Contrary to the present study, a recent study advocated the use
of a helmet for moderate to severe skull deformation. Both this
and our study had an equal intervention period: therapy started
at 6months of age and ended at 10months on average. However,
the recent study was a non-randomised study with no blinded
assessors, using different time intervals of follow-up and a
non-validated outcome measure.30
Previous studies often did not comprise long term outcomes
and systematic assessment of side effects. One retrospective
study described how 22.4% of infants experienced side effects
of helmet therapy. This is in contrast with our study, in which
side effects were reported in all infants, probably because we
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used a broader definition of side effects and side effects were
self reported by the parents.48Additionally, the clinical meaning
of the effects of helmet therapy presented in previous studies
can be disputed.34 In the present study we defined a clinically
meaningful difference as 4 oblique diameter difference index
points or 5 cranioproportional index points, consistent with one
level of severity in skull deformation according to
plagiocephalometry criteria (fig 2). We chose this cut-off point
based on expert opinion, and it should represent a difference
that is clinically visible. Both our randomised study design and
its focus on clinically meaningful differences, rather than just
significant differences, are strengths of this study compared
with previous studies.
In both arms of this study, brachycephaly showed a more
favourable course of recovery than plagiocephaly. A cohort
study of 129 infants with skull deformation at age 6 months
showed comparable results at age 4 years when the natural
course was awaited: the improvement in plagiocephaly (oblique
cranial length ratio at age 6 months: 108.6 (SD 3.3); age 4 years:
105.4 (SD 2.6)) is almost equal to the mean change score at age
5 months to 24 months of the natural course group (oblique
diameter difference index 3.1 (SD 3.3)) in the present study.
The improvement of brachycephaly (cephalic index at age 6
months: 92.6 (SD 6.6); age 4 years: 87.0 (SD 4.7)) is also in
line with findings in the natural course group in the present
study (change score on cranioproportional index from 5months
to 24 months 6.8 (SD 4.4)).21
Finally, interpreting parent reported outcomes can be difficult.
As in other studies, the objective outcomes in this study did not
match the subjective assessments.27 49 50 Non-clinical factors
may be as important as clinical factors in assessments of
satisfaction.51
Practice implications
This study indicates that helmet therapy has no added value in
the treatment of moderate to severe skull deformation in healthy
infants. A cost study performed in both arms of the present
study, parallel to the HEADS effectiveness study, showed that
the total costs per infant treated with a helmet were substantially
higher (n=20, €1401; £1157; $1935) than for infants in whom
the natural course of skull deformation was awaited (n=14,
€157).52 Based on the equal effectiveness of helmet therapy
compared with the natural course, the high prevalence of side
effects and the high costs of treatment, we discourage the use
of helmet therapy as a standard treatment for healthy infants
with moderate to severe skull deformation. Outcomes are
expected to hold for all types of custom-made helmets
comprising a rigid plastic shell with a foam lining that are
designed to fit snugly over the infant’s head and leaving room
for skull growth at the flattened area.
This conclusion is therefore likely to affect decisions of parents,
policymakers, insurance companies, and a wide range of
clinicians such as paediatricians, general practitioners, youth
healthcare professionals, paediatric physiotherapists, orthotists,
paediatric neurosurgeons, and craniofacial surgeons
internationally.
Our study also indicated that 75% of infants continued to have
some degree of skull deformation at 2 years of age, mainly the
plagiocephalic component. Skull deformation does not
completely resolve in all cases by natural course, and helmet
therapy does not seem to have an added value for recovery.
Therefore we emphasise the importance of prevention, early
detection, and early treatment with paediatric physiotherapy of
skull deformation.22 35 47 Additionally, our cut-off points for
normal head shape might be rigid in comparison with others.2 53
Therefore, the 75% of infants with persisting skull deformation
in the present study could be an overestimation of the prevalence
of the condition at an older age. It remains arguable what an
acceptable head shape is in young infants and at an older age
when the head is covered with hair.
Unanswered questions and future research
This is the first randomised controlled trial on helmet therapy
in infants with positional skull deformation. Although we
conclude no significant difference, this study was not powered
for equivalence. Ideally, the study should be repeated with an
adequate sample size to confirm the non-inferiority of helmet
therapy. However, we question whether aiming for another
randomised controlled trial will be realistic since helmet therapy
is not reimbursed in most countries. Results from the HEADS
non-randomised controlled trial will be presented in the near
future and might provide additional evidence to set next to the
results of the present randomised controlled trial. Future research
should determine the effects of helmet therapy in very severe
skull deformation.
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What is already known on this topic
Positional skull deformation is common in infancy
Helmet therapy is often prescribed in infants with positional skull deformation
Evidence from randomised controlled trials for the effectiveness of helmet therapy compared with the natural course of the condition is
lacking
What this study adds
No effect of helmet therapy can be shown in infants with moderate to severe positional skull deformation
All parents reported side effects; however, helmet therapy did not influence infants’ motor development or health related quality of life
that any discrepancies from the study as planned (and, if relevant,
registered) have been explained.
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Tables
Table 1| Characteristics of study population of infants with skull deformation. Values are numbers (percentages)* unless stated otherwise
Natural course (n=42)Helmet therapy (n=42)Total population (n=84)Characteristics
29/42 (69)32/42 (76)61/84 (73)Boys
5.1 (0.3)5.1 (0.4)5.1 (0.4)Mean (SD) age at baseline (months)
24.6 (5.1)25.0 (3.5)24.8 (4.4)Mean (SD) age at follow-up (months)
19/39 (49)20/40 (50)39/79 (49)Birth rank (first born)
2/40 (5)4/42 (10)6/84 (7)Health problems†
1/36 (3)4/41 (10)5/77 (7)Ethnicity (ethnic minority)‡
Education level of parents§:
9/39 (23)15/42 (36)24/81 (30)Low
19/39 (49)15/42 (36)34/81 (42)Medium
11/39 (28)12/42 (29)23/81 (28)High
Numbers may not add up to group totals because of missing data.
*Groups compared using t test or χ2 test.
†Problems with sight, hearing, oesophageal reflux, developmental dysplasia of hip, congenital heart disease, or inguinal hernia.
‡At least one parent born outside of the Netherlands.
§Low education level: lower technical and vocational training and lower general secondary education; medium education level: intermediate vocational training
and advanced secondary education; and high education level: higher vocational education and university. Percentages may not total 100%, due to rounding off.
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Table 2| Baseline clinical characteristics of study population at age 5 months. Values are means (standard deviations) unless stated
otherwise*
Natural course (n=42)Helmet therapy (n=42)Clinical characteristics
109.2 (2.9)107.2 (3.9)Plagiocephaly (ODDI)†
90.3 (6.2)93.4 (6.9)Brachycephaly (CPI)†
5.5 (3.0)4.7 (3.5)Ear deviation (EDI)
13 (31)7 (17)No (%) with facial asymmetry
10 (24)18 (43)No (%) with occipital lift
−0.7 (1.0)−0.7 (1.0)Motor development (AIMS Z-score)
3.0 (1.0)2.8 (0.8)Parental satisfaction
32.2 (8.6)30.8 (7.1)State anxiety (STAI-DY)
ODDI=oblique diameter difference index (value of 100% represents purely symmetrical head shape, value >100 represents asymmetrical skull deformation; the
higher the score, the more severe the deformation); CPI=cranioproportional index (score of 80% represents an average head shape in Western countries, higher
value represents a larger head width compared with length); EDI=ear deviation index (value of 0 represents no ear deviation; the higher the score above 0, the
more severe the ear deviation). AIMS=Alberta infant motor scale standardised Z scores (individual score minus average score divided by standard deviation);
STAI-DY=Dutch version of Spielberger state-trait anxiety inventory (scores range from 20 to 80; a higher score represents a higher state anxiety).
*Groups compared using t test or χ2 test.
†P<0.05.
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Table 3| Primary outcomes, measured at 24 months. Values are means (standard deviations) unless stated otherwise
ANCOVA; adjusted means (95% CI)†
P value*Natural course (n=40)Helmet therapy (n=39)Outcomes P valueNatural courseHelmet therapy
0.132.6 (1.8 to 3.4)3.4 ( 2.6 to 4.2)0.803.1 (3.3)2.9 (2.9)Plagiocephaly change score‡
0.207.4 (6.4 to 8.5)6.4 (5.3 to 7.5)0.816.8 (4.4)7.0 (4.1)Brachycephaly change score§
******0.749 (23)10 (26)No (%) with full recovery¶
ANCOVA=analysis of covariance.
*Groups compared using t test or χ2 test.
†ANCOVA model with baseline measurement at age 5 months as covariate.
‡Oblique diameter difference index at age 5 months minus at age 24 months.
§Cranioproportional index at age 5 months minus at age 24 months.
¶Oblique diameter difference index <104% and cranioproportional index <90%.
**Not analysed because of low number of cases.
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Table 4| Secondary outcomes, measured at age 24 months. Values are means (standard deviations) unless stated otherwise
Helmet therapy−natural courseP value*Natural course (n=40)Helmet therapy (n=39)Secondary outcomes
0.2 (−1.5 to 1.8)0.861.9 (3.6)2.0 (4.0)Ear deviation change score (n=79)†
0.4 (0.1 to 1.4)‡0.1710/39 (26)5/38 (13)No (%) with facial asymmetry
2.2 (0.4 to 13.0)‡0.362/40 (5)4/38 (11)No (%) with occipital lift
0.2 (−0.1 to 0.5)0.064.4 (0,6)4.6 (0.5)Parental satisfaction (n=77)
−3.9 (−7.5 to −0.2)0.0431.3 (9.2)27.4 (6.5)State anxiety (STAI-DY) (n=76)
−1.8 (−6.6 to 3.0)0.1799.0 (11.6)97.2 (9.4)BSID-III composite score (n=77)
−0.7 (−1.7 to 0.2)0.2110.8 (2.2)10.0 (1.9)BSID-III fine scale (n=78)
0.2 (−0.7 to 1.2)0.588.8 (2.4)9.1 (1.8)BSID-III gross scale (n=78)
STAI-DY=Dutch version of Spielberger state-trait anxiety inventory (scores range from 20 to 80; a higher score represents a higher state anxiety); BSID III=Bayley
scales of infant and toddler development, third edition (standardised motor composite scores mean 100 (SD 15), scaled scores for fine and gross motor development
mean 10 (SD 3).
*Groups compared using t test or χ2 test.
†Ear deviation index measurement at age 5 months minus at age 24 months.
‡Odds ratio (95% confidence interval).
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Figures
Fig 1 Flowchart of HElmet therapy Assessment in Deformed Skulls study
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Fig 2 Plagiocephalometry and cut-off points for severity of skull deformation. Illustration shows left occipital flattening of
skull and thermoplastic measuring ring with digitally drawn lines used in plagiocephalometry. Indices were calculated by
the following formulas: cranioproportional index, sinistra-dextra/anterior-posterior×100%; oblique diameter difference index,
longest oblique diameter/shortest oblique diameter×100%; and ear deviation index, ear deviation/anterior-posterior×100%
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